Literature DB >> 3554640

Renal function after kidney transplantation in children. A comparison of conventional immunosuppression with cyclosporine.

P F Hoyer, H P Krohn, G Offner, D J Byrd, J Brodehl, K Wonigeit, R Pichlmayr.   

Abstract

Clearance studies were performed in 32 transplanted children treated with CsA in combination with low-dose prednisolone (CsA group), and the results were compared with those of 29 children transplanted earlier and treated with azathioprine and prednisolone (CIS group). Serum creatinine and urea levels 6 weeks and 1 year after transplantation (Tx) were significantly higher in the CsA than in the CIS group. Clearance studies 6 weeks after Tx exhibited significantly lower rates in the CsA group: Cin = 47 +/- 16.5 versus 83 +/- 25 ml/min/1.73 sqm, CPAH = 271 +/- 110 versus 503 +/- 181 ml/min/1.73 sqm (P less than 0.001). The filtration fractions were not different (19.1 versus 17.1%). The tubular phosphate reabsorption per ml GFR (Tp/Cin) was only slightly lower in the CsA group (0.76 +/- 0.23 mumol/ml versus 0.93 +/- 0.29; P = 0.09). The endogenous glucose clearance rates were equally elevated in both groups and returned to normal after 1 year. The creatinine clearance (Ccr) had dropped in both groups by a mean for 13 ml/min/1.73 sqm between 6 weeks and 1 year after Tx. No correlation was found between the Ccr and the CsA blood levels, but Ccr was inversely correlated with the number of rejection episodes (r = -0.72, P = 0.001). In conclusion, renal allografts in CsA-treated children exhibited a significantly lower function than in CIS-treated children. The effect was related to the global kidney function without any signs of additional tubular toxicity and was apparent within the first weeks after Tx. Thereafter, the decline in graft function was comparable in both groups and could not be related to CsA treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3554640     DOI: 10.1097/00007890-198704000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  11 in total

1.  Renal function following kidney transplantation in children treated with cyclosporine.

Authors:  U B Berg; A B Bohlin
Journal:  Pediatr Nephrol       Date:  1992-07       Impact factor: 3.714

Review 2.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Renal handling of magnesium in transplanted children under cyclosporin A treatment.

Authors:  F Krull; P F Hoyer; G Offner; J Brodehl
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

Review 4.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

5.  Growth and pubertal development in nephropathic cystinosis.

Authors:  L Winkler; G Offner; F Krull; J Brodehl
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

6.  Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine.

Authors:  N Gordjani; G Offner; P F Hoyer; J Brodehl
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

7.  End stage renal failure: 14 years' experience of dialysis and renal transplantation.

Authors:  G Offner; C Aschendorff; P F Hoyer; H P Krohn; J H Ehrich; R Pichlmayr; J Brodehl
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

8.  Cyclosporin A in paediatric kidney transplantation.

Authors:  G Offner; P F Hoyer; J Brodehl; R Pichlmayr
Journal:  Pediatr Nephrol       Date:  1987-04       Impact factor: 3.714

9.  Renal handling of uric acid under cyclosporin A treatment.

Authors:  P F Hoyer; I J Lee; B S Oemar; H P Krohn; G Offner; J Brodehl
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

10.  Acute rejection episodes after renal transplantation in children under cyclosporin A treatment.

Authors:  P F Hoyer; G Offner; H P Krohn; J Brodehl
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.